CLINICAL_TRIALS
trial_result
· 2012-01-05
Clinical Trial Update: Pharyngocise Dose Response Study [Phase 2, Phase 3]
Summary
The Pharyngocise dose-response study for dysphagia has completed its Phase 2/3 program, as reported in the clinical trials update.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University of Florida | Conditions: Dysphagia | Phase 2, Phase 3 | Status: COMPLETED